Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

about

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

Item

http://www.wikidata.org/entity/Q45846222

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

@en

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

@nl

type

Item

label

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

@en

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

@nl

prefLabel

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

@en

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.

@nl

P1476

Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years

@en

P2093

Eetu Heervä

http://www.w3.org/2001/XMLSchema#string

Juha Peltonen

http://www.w3.org/2001/XMLSchema#string

Kalervo Väänänen

http://www.w3.org/2001/XMLSchema#string

Pekka Leinonen

http://www.w3.org/2001/XMLSchema#string

Sirkku Peltonen

http://www.w3.org/2001/XMLSchema#string

Tommi Kuorilehto

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France

The neurofibromatosis type 1 gene encodes a protein related to GAP

Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.

Generalized metabolic bone disease in Neurofibromatosis type I

Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body.

Osteoporosis prevention, diagnosis, and therapy.

The pathoetiology of neurofibromatosis 1

Bone mineral density in children and adolescents with neurofibromatosis type 1.

Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry.

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

P2888

s00223-012-9661-y

P304

23-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00223-012-9661-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Pöyhönen

P577

2012-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232738223

http://www.w3.org/2001/XMLSchema#string

P6179

1044905408

http://www.w3.org/2001/XMLSchema#string

P698

23108390

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis